Category Archives: Press Releases

Featured Stories

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

Smokers More Vulnerable to Joint Replacement Failures

People who smoke cigarettes before and after receiving a total joint replacement, such as a hip replacement device or knee implant, are far more likely to endure revision surgeries on those implants than people who don’t smoke.

Read More

MTA Bus Crash and Two Cars Injures 23 at Utica Ave. & Clarendon Rd

Crash Involving MTA Bus and Two Cars Injures 23

Police are investigating an accident in Brooklyn on Wednesday afternoon that injured 23 people, 3 of them critically, when a car was knocked into the path of an MTA bus.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Bronx Teenager Killed in Hit-and-Run, Second Teen Injured

A Port Jefferson Station man was killed on Wednesday in a single-vehicle crash on the Northern State Pkwy in Dix Hills west of Exit 42. He was driving a Nissan Altima.

Read More

Actos Bladder Cancer Lawsuit Filed by West Virginia Resident

Actos (pioglitazone) continues to be named in lawsuits alleging long-term use of the type 2 diabetes drug caused patients to develop bladder cancer. Just last week, the national law firm of Parker Waichman LLP filed suit against Takeda Pharmaceuticals on behalf of a West Virginia man who developed bladder cancer ...

Read More

Parker Waichman Lobbied in Congress Yesterday for Permanent Zadroga Act Extension

Parker Waichman was among the many who lobbied Congress to permanently extend the 2010 Zadroga Act and ensure first responders, survivors, and their families receive full benefits under the Act’s two programs. Parker Waichman LLP, a national law firm that … Continue reading

Posted in Accident, Health Concerns, Legal News, Press Releases, Toxic Substances |

FealGood Foundation Founder Urges Congress to Permanently Extend Zadroga Act

Parker Waichman will be among the many supporters of the Zadroga Act —including including Jon Stewart, formerly of “The Daily Show” and John Feal, founder of the FealGood Foundation advocacy group—lobbying for the Act’s permanent extension on September 16, 2015. … Continue reading

Posted in Accident, Asbestos, Benzene, Health Concerns, Legal News, Press Releases, Toxic Substances |

FDA Launches OpenFDA, Public Access to Searchable Prescription Drug Data

Through a new initiative called open FDA, the Food and Drug Administration  (FDA) is releasing to the public searchable data sets on prescription drugs. In the pilot stage, openFDA provides information on millions of reports of adverse events in drug … Continue reading

Posted in Health Concerns, Pharmaceuticals, Press Releases |

Medtronic Agrees to $9.9 Million Settlement in Physician Kickback Case

The Justice Department announced yesterday that Medtronic Inc. has agreed to pay the United States $9.9 million to resolve allegations that the company made illegal payments to physicians to induce them to implant Medtronic pacemakers and defibrillators. Assistant Attorney General … Continue reading

Posted in Legal News, Medtronic Defibrillators, Press Releases, Whistleblower |

Additional Cancers Now Covered Under Zadroga 9/11 Law

Parker Waichman LLP, a law firm that has fought to expand coverage for illnesses developed by 9/11 first responders, is pleased to announce that four additional cancers have been added to the list of cancers covered under the federal Zadroga … Continue reading

Posted in Health Concerns, Legal News, Press Releases, Toxic Substances, Zadroga Act Claims |

Study Shows Nearly 8% of Hip Implants Not Backed by Safety Evidence

8percent-hip-implants-not-safety-backed

A new study reveals that nearly eight percent of hip implant devices used in hip replacement surgery have no readily available evidence of safety or effectiveness. The study, published online last month in the British Medical Journal (BMJ), indicates that … Continue reading

Posted in Defective Medical Devices, Depuy, Health Concerns, Metal Hip Implants, Press Releases |

OxyElite Pro Recall Expanded to Include Flavored OxyElite Pro Super Thermo Powder

ocyelite-pro-super-thermo-powder--recall

USPlabs LLC just announced a recall of its OxyElite Pro Dietary Supplements over potential health risks and to now include Raspberry Lemonade OxyElite Pro Super Thermo Powder, among others. The recall includes all lots and sizes of specific dietary supplements, … Continue reading

Posted in Health Concerns, Pharmaceuticals, Press Releases, Product Recalls, Recalled Drugs, Toxic Substances |

Senators: Report Confirms Financial Gains Tied to PODs, Increased Surgery Trend

physician_profiting_surgery_trends

The United States Committee on Finance just released that U.S. Senators Orrin Hatch (Republican-Utah), Max Baucus (Democrat-Montana), and Chuck Grassley (Republican-Iowa) announced that a new report from the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) … Continue reading

Posted in Defective Medical Devices, Health Concerns, Legal News, Malpractice, Press Releases |

Parker Waichman LLP Designated as Co-Lead Counsel in Consolidation of Sandy-Related Litigation Against LIPA, National Grid

Parker_Waichman_Hurricane_Sandy

According to an order just filed on May 30, all Hurricane Sandy-related litigation brought against the Long Island Power Authority (LIPA) and/or National Grid now pending, as well as all subsequent filed actions, will be consolidated into one action before … Continue reading

Posted in Consumer Fraud, Legal News, Press Releases |

Parker Waichman LLP Takes on Credit Card Companies, Fights for Small Business

Credit_Card_Companies_Abuse

National law firm, Parker Waichman LLP, and co-counsel just filed an objection to the passage of a proposed $7.25 billion settlement of a price-fixing case brought against Visa Inc. and MasterCard Inc. over credit card transaction fees. Co-counsel—both based in … Continue reading

Posted in Legal News, Press Releases |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.